Answer
Dulaglutide suppresses glucagon secretion, which is inappropriately elevated in patients with type 2 diabetes, and the resulting lower glucagon concentrations decrease glucose output by the liver.
Sources for this answer
- TRULICITY 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 22Document updated
Sources checked